255 results on '"Ramos-Remus, Cesar"'
Search Results
2. Analysis of the image and corporate identity of the Colegio Mexicano de Reumatologia: Is it time to redefine it?
3. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023
4. Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023
5. Gender representation in rheumatology journals: an assessment of editors, editorial boards, and authors
6. Evaluation of the quality and subsequent performance of manuscripts rejected by Clinical Rheumatology: a research report
7. Overexpression of TLR7 and TLR9 Occurs Before Onset Symptoms In First-Degree Relatives of Rheumatoid Arthritis Patients
8. Recommendations of the Mexican College of Rheumatology for the management of spondyloarthritis
9. Recomendaciones del Colegio Mexicano de Reumatología para el manejo de las espondiloartritis
10. Subclinical inflammation in the preclinical phase of rheumatoid arthritis might contribute to articular joint damage
11. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
12. Assessment of SpondyloArthritis International Society (ASAS) consensus on Spanish nomenclature for spondyloarthritis
13. Consenso ASAS en nomenclatura en español para las espondiloartritis
14. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
15. Trends of Informed Consent forms for industry-sponsored clinical trials in rheumatology over a 17-year period: Readability, and assessment of patients’ health literacy and perceptions
16. Readability, Relevance and Quality of the Information in Spanish on the Web for Patients With Rheumatoid Arthritis
17. Legibilidad, relevancia y calidad de la información en español en la Web para pacientes con artritis reumatoide
18. La importancia de mantener los nombres propios de las instituciones: un caso contra la traducción.
19. Burden of rheumatoid arthritis on patients’ work productivity and quality of life
20. Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey
21. The use of reporting guidelines in rheumatology—a cross-sectional study in over 850 manuscripts published in five major rheumatology journals
22. Analysis of the linguistic strengths and weaknesses of abstracts submitted to the XLIX Mexican Congress of Rheumatology
23. Fifteen-year trend in information on the World Wide Web for patients with rheumatoid arthritis: evolving, but opportunities for improvement remain
24. The Use of Reporting Guidelines in Rheumatology: A Cross-Sectional Study of Over 850 Manuscripts Published in 5 Major Rheumatology Journals.
25. Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis
26. Ranking the importance of their own diseases: A positioning analysis in rheumatic patients and their proxies
27. Anti-transglutaminase, antigladin and ultra purified anti-gladin antibodies in patients with a diagnosis of rheumatoid arthritis
28. Non-Coding RNAs in Rheumatoid Arthritis: Implications for Biomarker Discovery
29. Divergent perceptions in health-related quality of life between family members and patients with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis
30. The number needed to offend: a cross-sectional study of potential offensiveness of rheumatic diagnostic labels
31. An infodemiology approach to assess the impact of unemployment on anxiety and depression in France.
32. Autoantibodies in Prediction of the Development of Rheumatoid Arthritis Among Healthy Relatives of Patients With the Disease
33. Beyond the joints: Neurological involvement in rheumatoid arthritis
34. Fifteen-year trends of long-term disability and sick leaves in ankylosing spondylitis
35. Complementary and alternative practices in rheumatology
36. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
37. Latitude gradient influences the age of onset in rheumatoid arthritis patients
38. Deflazacort: A glucocorticoid with few metabolic adverse effects but important immunosuppressive activity
39. Deflazacort induced stronger immunosuppression than expected
40. An infodemiology approach to assess the impact of unemployment on anxiety and depression in France
41. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
42. Neurological Involvement in Rheumatoid Arthritis
43. Atlantoaxial Subluxation in Ankylosing Spondylitis
44. Autonomic Dysfunction in Fibromyalgia Assessed by the Composite Autonomic Symptoms Scale (COMPASS)
45. In regard to a published article: the need to improve the quality of scientific literature in Spanish/Respecto a un articulo publicado: en pos de una literatura cientifica en espanol de mayor calidad
46. The OPTION trial: inhibition of the interleukin-6 receptor with tocilizumab in patients with rheumatoid arthritis
47. Análisis de las fortalezas y deficiencias lingüísticas de los resúmenes enviados para el XLIX Congreso Mexicano de Reumatología
48. Tocilizumab in systemic sclerosis:a randomised, double-blind, placebo-controlled, phase 3 trial
49. Evaluation of the Efficacy of Etoricoxib in Ankylosing Spondylitis: Results of a Fifty-Two–Week, Randomized, Controlled Study
50. New insights into culture driven disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.